Suppr超能文献

湿法制粒和片剂硬度对卡维地洛骨架片中药物溶出度的影响

Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?

机构信息

a KRKA, d. d. , Novo Mesto , Slovenia.

b Faculty of Pharmacy , University of Ljubljana , Ljubljana , Slovenia.

出版信息

Drug Dev Ind Pharm. 2018 Sep;44(9):1543-1550. doi: 10.1080/03639045.2018.1483394. Epub 2018 Jun 14.

Abstract

Wet granulation is mostly used process for manufacturing matrix tablets. Compared to the direct compression method, it allows for a better flow and compressibility properties of compression mixtures. Granulation, including process parameters and tableting, can influence critical quality attributes (CQAs) of hydrophilic matrix tablets. One of the most important CQAs is the drug release profile. We studied the influence of granulation process parameters (type of nozzle and water quantity used as granulation liquid) and tablet hardness on the drug release profile. Matrix tablets contained HPMC K4M hydrophilic matrix former and carvedilol as a model drug. The influence of selected HPMC characteristics on the drug release profile was also evaluated using two additional HPMC batches. For statistical evaluation, partial least square (PLS) models were generated for each time point of the drug release profile using the same number of latent factors. In this way, it was possible to evaluate how the importance of factors influencing drug dissolution changes in dependence on time throughout the drug release profile. The results of statistical evaluation show that the granulation process parameters (granulation liquid quantity and type of nozzle) and tablet hardness significantly influence the release profile. On the other hand, the influence of HPMC characteristics is negligible in comparison to the other factors studied. Using a higher granulation liquid quantity and the standard nozzle type results in larger granules with a higher density and lower porosity, which leads to a slower drug release profile. Lower tablet hardness also slows down the release profile.

摘要

湿法造粒主要用于制造基质片剂。与直接压缩法相比,它可以更好地改善压缩混合物的流动性和可压缩性。造粒(包括工艺参数和压片)会影响亲水性基质片剂的关键质量属性(CQAs)。其中最重要的 CQAs 之一是药物释放曲线。我们研究了造粒工艺参数(喷嘴类型和用作造粒液的水量)和片剂硬度对药物释放曲线的影响。基质片剂含有 HPMC K4M 亲水基质形成剂和卡维地洛作为模型药物。还使用另外两个 HPMC 批次评估了所选 HPMC 特性对药物释放曲线的影响。为了进行统计评估,针对药物释放曲线的每个时间点,使用相同数量的潜在因素为每个时间点生成偏最小二乘(PLS)模型。通过这种方式,可以评估在药物释放曲线的整个过程中,随时间变化影响药物溶解的因素的重要性如何变化。统计评估的结果表明,造粒工艺参数(造粒液量和喷嘴类型)和片剂硬度会显著影响释放曲线。另一方面,与研究的其他因素相比,HPMC 特性的影响可以忽略不计。使用更多的造粒液量和标准喷嘴类型会导致更大的颗粒,其密度更高,孔隙率更低,从而导致药物释放曲线更慢。较低的片剂硬度也会减缓释放曲线。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验